(MENAFN- ACCESSWIRE) ANKARA, TR / ACCESS Newswire / December 2, 2025 / GEN Pharmaceuticals (GENIL), Türkiye's leading specialty pharmaceutical company, has announced new positive results from its Phase 1 clinical trial evaluating the …

Study Continuation Follows Review of Site Level Data and Recommendation of Data Monitoring Committee BMS Remains Blinded to Study Data Bristol Myers Squibb (NYSE: BMY, "BMS") today announced that it will enroll additional patients in the ADEPT-2 …

Marina113/iStock via Getty Images Data from a phase 3 trial of Bristol Myers Squibb's (BMY) Cobenfy (xanomeline/trospium chloride) for Alzheimer's disease psychosis will be delayed as the drugmaker needs to enroll more patients following …

Bristol Myers Squibb & Co. (NYSE:BMY) on Wednesday said it would enroll additional patients in the ADEPT-2 Phase 3 study. The ADEPT-2 study is a multicenter, randomized, double-blind, placebo-controlled trial assessing the safety and efficacy of …

The phase 3 comeback story that Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year. The highly anticipated Adept-2 study will not read out by the year’s end as previously planned after BMS identified “ …

A closely watched readout for Bristol Myers Squibb’s Cobenfy in Alzheimer’s disease psychosis has been delayed to 2026 after the pharma was forced to recruit additional patients into the trial. In a press announcement on Wednesday, BMS said it detected “ …

FORTHCOMING BOOK TO EXPLORE ONE FAMILY’S JOURNEY AS WELL AS FAMILY SECRETS AND LORE, BECAUSE ALZHEIMER'S NEVER PRESENTS ITSELF ALONE IRVINE, CA, UNITED STATES, December 3, 2025 /⁨EINPresswire.com⁩/ -- Acorn Publishing, the largest publisher in …

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer's disease. A new JCI Insight study identifies a mechanism through which the young brain protects itself against high calcium levels, and it could help scientists …

In their late 70s, Paul and Gail never thought that they would have to choose between paying for medications or purchasing food. After working hard for over 40 years and carefully planning, they thought they had saved enough for retirement. But almost 20 …